Platelets are cell fragments involved in hemostasis and forming blood clots. They are produced in bone marrow and have a lifespan of 5 to 9 days. Abnormalities can cause low or high platelet counts and affect coagulation. Both thrombocytopenia and thrombocytosis can present with bleeding and clotting issues respectively. Common platelet disorders include immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura.
Platelets are cell fragments involved in hemostasis and forming blood clots. They are produced in bone marrow and have a lifespan of 5 to 9 days. Abnormalities can cause low or high platelet counts and affect coagulation. Both thrombocytopenia and thrombocytosis can present with bleeding and clotting issues respectively. Common platelet disorders include immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura.
Platelets are cell fragments involved in hemostasis and forming blood clots. They are produced in bone marrow and have a lifespan of 5 to 9 days. Abnormalities can cause low or high platelet counts and affect coagulation. Both thrombocytopenia and thrombocytosis can present with bleeding and clotting issues respectively. Common platelet disorders include immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura.
DEFINITION Platelets, or thrombocytes (from Greek θρόμβος, "clot" and κύτος, "cell") small, irregularly shaped clear cell fragments 2–3 µm in diameter derived from fragmentation of precursor megakaryocytes lifespan of a platelet is normally just in avg 5 to 9 days FUNCTION involved in hemostasis, leading to the formation of blood clots Pro-coagulation Inflammation Cytokine signalling Phagocytosis ABNORMALITY An abnormality or disease of the platelets is called a thrombocytopathy, which could be either a low number of platelets (thrombocytopenia), a decrease in function of platelets (thrombasthenia), or an increase in the number of platelets (thrombocytosis). ABNORMALITY There are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) or thrombotic thrombocytopenic purpura (TTP) that typically cause thromboses, or clots, instead of bleeding. KINETICS Platelets are produced in blood cell formation (thrombopoiesis) in bone marrow, by budding off from megakaryocytes. The physiological range for platelets is (150– 400)×109per liter. Around 1011 platelets are produced each day by an average healthy adult. The lifespan of circulating platelets is 5 to 9 days. KINETICS Megakaryocyte and platelet production is regulated by thrombopoietin, a hormone usually produced by the liver and kidneys. Each megakaryocyte produces between 5,000 and 10,000 platelets. Old platelets are destroyed by phagocytosis in thespleen and by Kupffer cells in the liver. Reserve platelets are stored in the spleen, and are released when needed by sympathetically induced splenic contraction. DISEASE Role A normal platelet count in a healthy individual is between 150,000 and 450,000 per μl (microlitre) of blood ((150–450)×109/L) Both thrombocytopenia and thrombocytosis may present with coagulation problems. In general, low platelet counts increase bleeding risks; however there are exceptions (such as immune- mediated heparin-induced thrombocytopenia or paroxysmal nocturnal hemoglobinuria). High counts may lead to thrombosis, although this is mainly when the elevated count is due to myeloproliferative disorder. DISEASE Disorders leading to a reduced platelet count: Thrombocytopenia Idiopathic thrombocytopenic purpura – also known as immune thrombocytopenic purpura (ITP) Thrombotic thrombocytopenic purpura Drug-induced thrombocytopenic purpura (for example heparin-induced thrombocytopenia (HIT)) Gaucher's disease Aplastic anemia Onyalai DISEASE Alloimmune disorders Fetomaternal alloimmune thrombocytopenia Some transfusion reactions Disorders leading to platelet dysfunction or reduced count: HELLP syndrome Hemolytic-uremic syndrome Chemotherapy Dengue DISEASE Disorders featuring an elevated count: Thrombocytosis, including essential thrombocytosis (elevated counts, either reactive or as an expression of myeloproliferative disease); may feature dysfunctional platelets Disorders of platelet adhesion or aggregation: Bernard-Soulier syndrome Glanzmann's thrombasthenia Scott's syndrome von Willebrand disease Hermansky-Pudlak Syndrome Gray platelet syndrome DISEASE Disorders of platelet metabolism Decreased cyclooxygenase activity, induced or congenital Storage pool defects, acquired or congenital Disorders that indirectly compromise platelet function: Haemophilia Wiskott–Aldrich syndrome DISEASE Disorders in which platelets play a key role: Atherosclerosis Coronary artery disease, CAD and myocardial infarction, MI Cerebrovascular disease and Stroke, CVA (cerebrovascular accident) Peripheral artery occlusive disease (PAOD) Cancer Malaria non vi è alcuna blu nel mio sangue
Raising Mentally Strong Kids: How to Combine the Power of Neuroscience with Love and Logic to Grow Confident, Kind, Responsible, and Resilient Children and Young Adults
Dark Psychology & Manipulation: Discover How To Analyze People and Master Human Behaviour Using Emotional Influence Techniques, Body Language Secrets, Covert NLP, Speed Reading, and Hypnosis.